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ABSTRACT 
Advances in biology sciences over the past decade have provided additional technology for dealing 
with trematode parasitoses. Although trematode diseases of man and animals in Indonesia are essentially 
the same as they were ten years ago, scientific methods available to deal with them have improved 
significantly. One can now exploit the innate ability of cells to replicate and produce biological products 
upon demand, manipulate the genetic make up of an organism, biologically or synthetically manufacture 
peptides and rationally develop drugs that target idiosyncrasies of parasites at the cellular and molecular 
levels. Further, one can now manage and analyze massive amounts of biological data using desk top 
computers. These new biological techniques and the computing ability to interpret the data generated 
provide parasitologists in Indonesia and elsewhere with the ability to document the economic and public 
health impact of trematode parasitoses and to develop new strategies and reagents for diagnosing, treating, 
preventing and controlling the diseases they cause. In addition, biotechnology offers university scientists 
and their students with additional opportunities to investigate basic and esoteric aspects of host-parasite 
interrelationship that are such an intriguing aspect of biology. 
INTRODUCTION ject of a separate review. This paper will 
Trematode parasites in Asia and the discuss other trematodes of interest to 
basic strategies available for their control parasitologists in Indonesia and review con- 
and/or eradication have been available for ventional and novel applications of new tech- 
decades. Parasite idiosyncrasies are iden- nologies that have enhanced our under- 
tified to make them easier to diagnose, more standing of the basic biology of trematodes 
susceptible to prophylaxsis/therapy, or suc- and, hopefully, will lead to their control or 
cumb to environmental control measures. eradication. It should be emphasized, how- 
Schistosomiasis has been the focus for most ever, that current research efforts on schis- 
applications of recent biotechnological tosomiasis will provide valuable information 
developments and it is appropriately the sub- on the biology and biochemistry of trematodes 
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in general. This information will benefit sub- 
sequent studies of other trematode diseases of 
economic or public health importance to In- 
donesia. 
Table 1 lists the major trematode 
parasitoses of Indonesia and neighbouring 
countries. Approximately 10 percent of 
recent literature on the application of new 
technology involved trematode parasitoses 
other than schistosomiasis. The minimal ap- 
plication of new biotechnologies to other 
trematode disease clearly underlines the im- 
portance of this conference. Modem biologi- 
cal tools, where applicable, can and should to 
combat other trematode diseases in Asia of 
economic and public health importance. 
Diagnosis 
The influence of molecular hetero- 
genicity on the identification and immuno- 
diagnosis of trematodes was summarized by 
Simpson (1987). Hybridoma technology has 
proved extremely effective in the field of 
immunodiagnosis. Specific and generic 
monoclonal antibodies have been developed 
to identify antigens of a variety of trematodes 
for use in serodiagnostic tests or as probes for 
specific segments of genomes. (Norden and 
Strand, 1984a, 1984b, Mott et al., 1987; 
Kobayashi, 1986, Feldmeir et al.,  1986; 
Noguiera-Queiroz et al., 1986; Harn et al., 
1985; McCutchan etal., 1984; Mitchell etal., 
1983; Feng et al., 11985; Sirisinha, 1988). 
Trudgett etal. (1988) Monoclonal antibodies, 
specific for tegumental antigen of Fasciola 
hepatica, were used as a solid phase immuno- 
sorbant for purification of tegmental antigen 
from adult liver fluke homogenates and these 
antigens were subsequently used in im- 
munoassays for F. hepatica antibody in sheep 
and cattle. 
DNA probes have proved both sensitive 
and specific in the identification of protozoan 
infections (Berry and Peter, 1984) and can be 
purchased commercially in diagnostic kits 
(Klausner and Wilson, 1983 and Olsiewski et 
al., 1984). The use of recombinant DNA tech- 
nology for identification of helminths has just 
begun, but it will prove to be a valuable tool 
for the purpose. Rollison et al. (1986) have 
investigated nuclear DNA, as diagnostic 
probe, for detection of schistosome infec- 
tions. Sirisinha (1988) has identified, charac- 
terized and is attempting to clone the genes 
that code for candidate diagnostic protein of 
Ophisthorchis viverrini which is found in 
adults, metacercariae, somatic extracts and 
metabolic products. 
Vaccines 
The size of the genome varies with the 
complexity of the organism and the difficulty 
of developing rational vaccines. The genomic 
size of DNA viruses is around 200 thousand 
base pairs and protozoans have about 40 mil- 
lion base pairs. In contrast, helminth genomes 
are in the order of 200 - 400 million base pairs 
(Simpson et al., 1982). The relatively large 
size of helminth genomes is one reason why 
hybridoma and recombinant DNA tech- 
nologies have not had the impact on the 
development of vaccines against trematode 
parasites as they have had on less complicated 
organisms (Murray, 1987). 
Fascioliasis has been the target of a 
limited vaccine development efforts. Various 
attempts to stimulate resistance against fas- 
cioliasis were summarized recently by 
Haroun and Hillyer (1986). Fascioliasis vac- 
cine development has been focused on iden- 
tification and characterization of antigens, 
particularly those antigens shared with Schis- 
tosoma mansoni (Hillyer, 1984). Most recent 
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Table I. Trematode Parasitoses of Indonesian and Neighbouring countries. 
Clonorchiasis 
Dicrocoeliosis 
Eurytrematosis 
Echinostomiasis 
Fascioliasis 
Fasciolopsiasis 
Heterophy idiasis 
Opisthorchiasis 
Paragonimiasis 
Paramphistomiasis 
Schistosomiasis 
reports characterize tegument antigens which 
cross- react with surface glycoproteins of S. 
mansoni (Aronstein et al.,  1985a, 1985b, 
1986; Rasmussen et al., 1986). Recently, Hil- 
lyer et al. (1988) reviewed the role of F. 
hepatica cross-reactive antigens in acquired 
immunity to schistosomes and presented an 
update of their own efforts to isolate and 
characterize a 12kD polypeptide of F. 
hepatica that induces 50 to 80% protection in 
mice challenged with S. mansoni. 
Monoclonal antibodies developed 
against F. hepatica antigens are reported to 
protect against challenge with S. mansoni cer- 
cariae (Hicks and Doughty,, 1987) and 
soluble tegument antigens of F. hepatica can 
provide protection to mice exposed to lethal 
doses of S. mansoni cercariae (Hillyer and 
Serrano, 1982). 
Other reports describe the development 
of monoclonal antibodies to further charac- 
terize the tegument antigens present in T-1 
granules and the glycocalyx of F. hepatica 
(Hanna and Trudgett, 1983; Hanna et al., 
1988). Sloan et al. (1984) developed mono- 
clonal antibodies to immature liver fluke an- 
tigens in order to evaluate their immuno- 
protective potential. They have isolated an 
IgM producing cell line which reacted with 
the surface syncytium and tegument of newly 
excysted metacercariae, with the tegument 
and gut of juveniles, and with the gut of 
adults. Joshua and Bennett (1984) isolated a 
IgG monoclonal antibody that reacted with 
surface syncytium of F. hepatica and con- 
ferred 47 to 55% passive protection. 
Immunoglobulins have been detected on 
the surface of F. hepatica parasites harvested 
from immunocompetent animals and early 
surface protein labelling studies (Howard et 
al., 1980). It has been suggested that these 
immunoglobulins, which have been termed 
"blocking antibodies", might be converted to 
more aggressive antibody isotypes by selec- 
tive vaccination (Mitchell, 1989). 
Yan et al. (1988) and Feng et al. (1985) 
have attempted to isolate and characterize 
protective antigens of Paragonimus skrjabini 
using hybridoma technology. They have 
developed a series of monoclonal antibodies 
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that recognized specific antigens of P. 
skrjabini. 
Recombinant DNA approaches to 
trematode vaccine development, other than 
schistosomiasis, are still in their embryon;c 
stage. Zwrita et al. (1987) established a 
cDNA library for F. hepatica, and identified 
and sequenced a female organ-specific 
protein. Beardsell and Howell (1987a, b) 
have reproduced F. hepatica antigens through 
co-transformation of established murine cell 
lines with DNA from F. hepatica. This in 
vitro method of producing metazoan antigens 
allows eukaryotic cells to make post-transla- 
tional changes which are beyond the 
capabilities of prokaryotic organisms 
(Beardsell and Howell, 1987b). 
Future advances in the field of vaccine 
development will depend on a thorough un- 
derstanding of immune mechanisms and their 
regulation throughout the course of a parasitic 
infection. Basic host responses will provide 
the clues needed to identify which of the 
many parasite antigens are relevant and 
biotechnology will provide techniques to iso- 
late and characterize relevant antigens. 
Hayunga (1989) postulated that one reason 
"high tech" technologies so far have had little 
impact on the development of vaccines 
against trematodes is not that they are inap- 
propriate technologies, but they are examples 
of technology inappropriately applied. The 
information database on the immune 
mechanisms involved and their regulation 
throughout the course of a trematode infec- 
tion has been deficient. Knowledge of the 
basic biology, biochemistry and immuno- 
chemistry is essential for the appropriate ap- 
plication of "high tech" technology to vaccine 
development programs. 
Drug Development 
Most currently used antihelminthic 
drugs are products of trial and error approach. 
Modem biology offers a more rational 
method for drug design. The combination of 
biochemistry, molecular biology, protein 
structure analysis and computer-aided 
molecular modelling provide the means to 
elucidate the mode of action of currently used 
drugs and exploit the differences that exist 
between the metabolism of the parasite and 
the host in the design of new generation of 
antiparasitic drugs (Hart et al., 1989). 
Recombinant D N A  technology is a 
quick, powerful and efficient method for dis- 
secting numerous parasite-related 
peculiarities which are potential targets for 
drug development. In addition, nuclear mag- 
netic resonance spectroscopy (NMR) is now 
used in place of more traditional techniques 
for looking at enzymes and metabolites of 
parasites. Living parasites can be examined 
with NMR technology. The presence of 31P 
(natural phosphorus) and 13C (enriched) 
nuclei in parasites are determined to inves- 
tigate carbohydrate metabolism and produc- 
tion of cellular energy compounds in living 
parasites. Lipids and proteins containing 
natural phosphorus can also be monitored in 
living parasites. Matthews et al. (1985) 
demonstrated the possibility of obtaining 
good quality NMR spectra from intact F. 
hepatica maintained inn NMR tubes. More 
recently, Matthews and Mansour (1987) 
reviewed their application of NMR to inves- 
tigations of glycolytic metabolism and phar- 
macology of F. hepatica. A prime interest 
of this group is the metabolism of adenylate 
cyclate, which catalyzes conversion of ATP 
to cyclic AMP. 
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Parasite Genetics 
When isoenzyme electrophoresis was 
introduced 20 years ago, it was considered the 
first major advance in technology for phylo- 
genetic analyses in 50 years. Isoenzyme 
electrophoresis, however, is appropriate for 
determining the relationship of organisms 
that are closely related (Richardson et al., 
1986). Recombinant DNA technology is 
providing insight into the molecular evolu- 
tion of trematodes and other helminths for this 
technology is able to directly measure varia- 
tion. Antigens, isolated and characterized for 
whatever purpose, are also excellent tools for 
probing the phylogenetic relationships be- 
tween helminths (Simpson, 1987). Most 
modem molecular methods are time-consum- 
ing and technically difficult; however, a 
newly described technique for rapidly obtain- 
ing the partial nucleotide sequence of 
ribosomal RNA is not as time-consuming and 
technically =cult (Johnson and Baver-stock, 
1989). Tbis technique is being applied to inves- 
tigate phylogenetic relationships among or- 
ganisms. Liang et al. (1986) discussed the 
importance of this method to helminth 
phylogeny and demonstrated the usefulness 
and generality or recombinant RNA sequenc- 
ing for the systematic phylogenetic classifica- 
tion of parasitic organisms whose tissues are 
only available in relatively small amounts. 
Host Genetics 
Scientists, interested in the interruption 
of disease transmission, have two basic 
choices. The focus of most efforts has been to 
modify host resistance or susceptibility 
through immuno- or chemoprophylaxis or 
therapy. The other approach is simply to 
mod@ the host's genome through introduc- 
tion genetic characteristics that are con- 
sidered protective. Traditionally this was- 
done through selective breeding. Molecular 
genetics and recombinant DNA technology 
now provide the ability to introduce resis- 
tance in an artificial manner (Murrell, 1983). 
Williams (1987) and Albers and Gray (1987) 
recently reviewed host genetic resistance and 
breeding for resistance to parasites and Sher 
et al .  (1987) specifically discussed host 
genetic control of protective immunity to 
schistosomes. A basic understanding of the 
molecular basis for resistance coupled with 
the ability to alter the genome of a species 
offer the opportunity to modify the host 
genetically to tip the hostjparasite balance in 
favor of the host in order to reduce or 
eliminate transmission. 
Bioengineering 
The durability of trematode egg shells is 
well recognized. Bioengineers are interested 
in the molecular structure of trematode egg 
shells as they represent novel protein 
biopolymers with potential application in the 
development of protective paints or biologi- 
cally based glues. Cordinley (1987) reviewed 
recombinant DNA studies that have shed light 
on the formation of schistosome and Fasciola 
egg shell structures. These and other studies 
suggest that many phylogenetically didant 
organisms are exploiting cross linking 
chemistry of certain polypeptides for the con- 
struction of protein polymers and several 
commercial firms are actively trying to dupli- 
cate these biological glues and polymers in 
bacterial systems. 
Basic Biology 
Although the primary interest in the ap- 
plication of biotechnology to trematode dis- 
eases is the potential of these technologies to 
reduce their associated morbidity and mor- 
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tality, the more immediate benefit has been 
the increase in knowledge of host-parasite 
relationships. Parasites have provided with 
excellent tools for unraveling the com- 
plexities of species interactions at the 
molecular, cellular, organismal and popula- 
tion levels. Thus, regardless of the practical 
outcome of the current wave of new tech- 
nologies on trematode parasitoses, the result- 
ing increase in knowledge of the basic 
relationships between hosts and their 
parasites will be of immense value. In turn, 
improved understanding of host-parasite 
relationships at the molecular level will con- 
tinue to expose parasite idiosyncrasies that 
will make them susceptible to accurate diag- 
nosis, treatment, prevention or control 
through new biotechnologies. 
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QUESTIONS AND ANSWERS : 
1. Question: Usually the "~s-release is used to show damage or killing of the labeled cells. The system 
you used showed the blockin effect of M0A.b. Did the effect indicate the specific binding 
5 lg to any receptor and did the Cs-release occur due partly to "shedding phenomena" of the 
surface membrane ? 
Answer: The data imply the 150.000 MW molecule is involved in the cytopathic/cytotoxic 
mechanism although further experiments using purified Tf150 need to be done (icy 
competition experiments) or (direct assay of 150 on targets). 
2 .  Question: What is the crucial nature of the idiosyncracy should be studied in immunological or 
biotechnological engineering. 
Answer : One should look for specific antigens or metabolic pathways that are unique to the parasite. 
These antigens or metabolites can then be targeted by antibodies or chemotherapeutic 
agents. 
3. Question: Has there been any biotechnological research which proved that the Schistosome found in 
Asia and Southeast Asia are all similar species ? 
If no, what will be the appropriate method of biotechnology. 
Answer : Yes, Fletcher et a1 showed that S.mekongi had a closer evolutionary relationship with 
S.japonicum compared to S.mansoni. Time of divergence in millions of years calculated 
from isozyme analysis fits well with similar calculation using non-isozyme techniques. 
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